Table 1.

BTK mutations identified via whole-exome sequencing and digital droplet polymerase chain reaction in patients with CLL after relapse with tirabrutinib

PatientBTK amino acid changeWT codonMutant codonCCF from WES (%)VAF from ddPCR (%)
CLL-1 L528W TTG TGG 86.8 78.6 
CLL-2 C481S TGC TCC Not called 16.4 
CLL-3 None detected 
CLL-4 C481S TGC TCC 22.4 34.5 
 T474I ACT ATT 50.4 62.4 
CLL-5 L528W TTG TGG 91.0 79.3 
CLL-6 C481S TGC TCC Not detected 1.9 
 L528W TTG TGG Not detected 0.71 
 T474I ACT ATT 34.4 12 
 E108K GAA AAA 56.9 Not tested 
CLL-7 None detected 
CLL-8 C481S TGC TCC Not called 17.9 
 C481S TGC ACG Not called 5.3 
 L528W TTG TGG Not detected 0.16 
 T474I ACT ATT 5.0 5.8 
CLL-9 None detected 
PatientBTK amino acid changeWT codonMutant codonCCF from WES (%)VAF from ddPCR (%)
CLL-1 L528W TTG TGG 86.8 78.6 
CLL-2 C481S TGC TCC Not called 16.4 
CLL-3 None detected 
CLL-4 C481S TGC TCC 22.4 34.5 
 T474I ACT ATT 50.4 62.4 
CLL-5 L528W TTG TGG 91.0 79.3 
CLL-6 C481S TGC TCC Not detected 1.9 
 L528W TTG TGG Not detected 0.71 
 T474I ACT ATT 34.4 12 
 E108K GAA AAA 56.9 Not tested 
CLL-7 None detected 
CLL-8 C481S TGC TCC Not called 17.9 
 C481S TGC ACG Not called 5.3 
 L528W TTG TGG Not detected 0.16 
 T474I ACT ATT 5.0 5.8 
CLL-9 None detected 

CCF calculated from WES and VAFs from ddPCR are included.

“Not detected” denotes mutations that were not called with our WES variant caller and were not visualized by eye in the raw sequencing read data.

“Not called” denotes mutations that were not detected with our WES variant caller but were visualized by eye on raw sequencing reads, likely because of low-confidence variant calling of low VAF mutations within low-coverage data.

CCF, cancer cell fraction; ddPCR, digital droplet polymerase chain reaction; VAF, variant allele frequency; WES, whole-exome sequencing; WT, wild-type.

Close Modal

or Create an Account

Close Modal
Close Modal